These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22528598)

  • 41. [Clinical trial of the month. The STENO-2 study: a plea for global and intensive management of the type 2 diabetic patient].
    Scheen AJ; Estrella F
    Rev Med Liege; 2003 Feb; 58(2):109-11. PubMed ID: 12693313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [EBM on diabetic microangiopathy].
    Iwamoto Y; Kitano S; Hase M; Takayama S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():25-31. PubMed ID: 15999681
    [No Abstract]   [Full Text] [Related]  

  • 43. Glycemic targets and cardiovascular disease.
    Cefalu WT
    N Engl J Med; 2008 Jun; 358(24):2633-5. PubMed ID: 18539919
    [No Abstract]   [Full Text] [Related]  

  • 44. Type 2 diabetes: target HbA1c of about 7%.
    Prescrire Int; 2009 Aug; 18(102):177. PubMed ID: 19746575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary.
    Iványi T; Fövényi J; Faludi P; Han J; Macconell L; Wille S; Kiljanski J
    Clin Ther; 2012 Jun; 34(6):1301-13. PubMed ID: 22608106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exenatide.
    Keating GM
    Drugs; 2005; 65(12):1681-92; discussion 1693-5. PubMed ID: 16060703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Periodic examination of patients with diabetes mellitus].
    van Ballegooie E; Casparie AF
    Ned Tijdschr Geneeskd; 1987 Dec; 131(51):2352-5. PubMed ID: 3696282
    [No Abstract]   [Full Text] [Related]  

  • 48. [Exenatide--an incretin-mimetic agent for the treatment of type 2 diabetes mellitus].
    Reuter H; Erdmann E
    Dtsch Med Wochenschr; 2007 Mar; 132(11):571-4. PubMed ID: 17342635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes complications. Proactive care a must.
    Mayo Clin Health Lett; 2012 Oct; 30(10):4-5. PubMed ID: 23133856
    [No Abstract]   [Full Text] [Related]  

  • 50. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aging process or metabolic abnormalities?--Constrollabilities of diabetic complications studied with correlation analysis.
    Hoshi M; Oji N; Inoue M; Araki N; Shichiri M
    Med J Osaka Univ; 1973 Dec; 24(3):155-9. PubMed ID: 4803937
    [No Abstract]   [Full Text] [Related]  

  • 52. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications.
    Donaghue KC; Chiarelli F; Trotta D; Allgrove J; Dahl-Jorgensen K;
    Pediatr Diabetes; 2007 Jun; 8(3):163-70. PubMed ID: 17550427
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents.
    Fang V; Wazny LD; Raymond CB
    CANNT J; 2012; 22(1):30-6; quiz 37-8. PubMed ID: 22558681
    [No Abstract]   [Full Text] [Related]  

  • 54. New medications help those with diabetes avoid heart trouble. Drugs mimic the body's natural insulin and glucose controls, but diet and exercise are still keys to controlling the disease.
    Heart Advis; 2007 Jul; 10(7):10-1. PubMed ID: 17695659
    [No Abstract]   [Full Text] [Related]  

  • 55. Exenatide as a treatment for diabetes and obesity: implications for cardiovascular risk reduction.
    Mafong DD; Henry RR
    Curr Atheroscler Rep; 2008 Feb; 10(1):55-60. PubMed ID: 18366986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetes.
    Greenfield JR; Chisholm DJ
    Aust N Z J Med; 2000 Aug; 30(4):483-91. PubMed ID: 10985515
    [No Abstract]   [Full Text] [Related]  

  • 57. Diabetes II: Can good control prevent degenerative complications of juvenile diabetes mellitus?
    Marr TJ; Traisman HS; Traisman ES
    J Kans Med Soc; 1982 Jun; 83(6):291-4. PubMed ID: 7108335
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of type 2 diabetes mellitus and the incretin system.
    Whitehill D
    S D Med; 2007 May; 60(5):197, 199. PubMed ID: 17694940
    [No Abstract]   [Full Text] [Related]  

  • 59. [Intensive therapy in type 2 diabetes. More damage than benefit?].
    Einecke D
    MMW Fortschr Med; 2008 Jun; 150(26-27):12-4. PubMed ID: 18681224
    [No Abstract]   [Full Text] [Related]  

  • 60. 3: Preventing complications of diabetes.
    Bate KL; Jerums G
    Med J Aust; 2003 Nov; 179(9):498-503. PubMed ID: 14583083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.